Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
61,965.79 +2,665.76 (+4.50%) CMC Crypto 200
1,341.30 +64.32 (+5.04%)
Moringa Acquisition Corp (MACA)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
As of 04:00PM EDT. Market open.
| Previous close | 11.16 |
| Open | 11.16 |
| Bid | 0.00 x 0 |
| Ask | 11.50 x 100 |
| Day's range | 11.33 - 11.33 |
| 52-week range | 10.32 - 11.51 |
| Volume | |
| Avg. volume | 564 |
| Market cap | 43.847M |
| Beta (5Y monthly) | 0.01 |
| PE ratio (TTM) | 22.22 |
| EPS (TTM) | 0.51 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireSilexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
Silexion’s first generation product, Loder™, successfully tested in a multinational Phase 2a clinical trial in patients with non-resectable pancreatic cancer which harbors an oncogene believed to be a major driver of the cancer In combination with chemotherapy, Loder resulted in a median overall survival (OS) advantage of 9.3 months over chemotherapy alone (22.7 vs 13.4 months) Modi’in, Israel and New York, New York, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (Nasdaq: MACA) (“Mor
© 2024 Yahoo. All rights reserved.